Seattle, WA -- (SBWire) -- 10/03/2019 --Global Hospital Acquired Disease Testing Market, by Test Type (Urinary Tract Infection, Surgical Site Infection, Pneumonia, Blood Stream Infection, Methicillin-resistant Staphylococcus Aureus, and others) and by Region North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Insights, Size, Share, Opportunity Analysis, and Industry Forecast till 2025
Hospital acquired disease also known as nosocomial infection is an infection that is acquired in a hospital or other healthcare facility. Hospital acquired infections results in prolonged hospital stay, antimicrobial resistance, long-term disabilities, and increase mortality rate. Various pathogens are responsible for hospital acquired such as viruses, fungal, parasites, and bacteria.
Get PDF Brochure of Research Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/992
Hospital acquired infection is emerging as a major burden for society, patients, and healthcare management
There are different types of hospital acquired disease such as catheter-related blood stream infection, surgical site infection, ventilator-associated pneumonia, and catheter-associated urinary tract infection. These infections predominantly occur in emerging economies globally. According Asia Pacific Journal of Tropical Medicine, in 2017, nosocomial infections accounted for around 10% in emerging economies and around 7% in developed economies out of all the infections. Furthermore, according to the World Health Organization (WHO), 2011, around 15% patients hospitalized suffered from above mentioned infections, due to exposure to pathogens through different sources, such as healthcare staff and infected patients. Newborn babies, especially in emerging economies, are also at high risk of developing hospital acquired infection. According to the WHO, 2011, the infection rate in newborns is 20 times higher in emerging economies as compared to high income economies.
However, nosocomial infections could be avoided by practicing infection control programs and adopting antimicrobial control policies. For instance, the National Health & Medical Research Council Australia (NHMRC), 2002, provided critical guidelines for the management of infections, prevention, and control in healthcare organizations.
The global hospital acquired disease testing market was valued at US$ 539 million in 2016 and is expected to witness a CAGR of 19.70% over the forecast period (2017 - 2025).
Detailed Segmentation:
Global Hospital-acquired Disease Testing market, By Test Type:
- Urinary Tract Infection
- Surgical Site Infection
- Pneumonia Stents
- Blood Stream Infection
- Methicillin-resistant Staphylococcus Aureus
- Others
Global Hospital-acquired Disease Testing market, By Geography:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
To Know More About Hospital-acquired Disease Testing Market Report: https://www.coherentmarketinsights.com/market-insight/hospital-acquired-disease-testing-market-992
Resistance to antibodies and expanded hospitalization is expected to drive growth of the global hospital acquired disease testing market in the near future
Increasing prevalence of nosocomial infections such as surgical wounds, urinary tract infections, and lower respiratory tract infections in intensive care units, orthopedic, and acute surgical ward is expected to boost the global hospital acquired disease testing market growth. Moreover, the technique used for preventions, diagnosis, and testing of hospital acquired diseases are microarray, PCR, and solid phase hybridization. The urinary tract infections is the most common in patients suffering from urinary catheter, as urethra is located close to the anus, which increases the changes of invasions of bacteria from large intestine into the urinary tracts. Thus, expenses and antibiotic resistance increase with extended hospitalization, which in turn, is expected to drive growth of global hospital acquired disease testing market.
Various dynamics such as favorable government initiatives towards nosocomial infections, regulatory guidelines, and reimbursement scenario are expected to boost the global hospital acquired disease testing market growth in North America and Europe. For instance, Medicare and private insurance companies are eliminating the reimbursement rate due to high rate of hospital acquired infection (HAI) incidence during 2014-2015, adding financial stress on hospitals to reduce hospital acquired diseases. However, unhygienic conditions and practices in emerging and underdeveloped regions is resulting in higher incidences of HAI in these regions, which is expected to restrain the market growth in the near future. Thus, there is an urgent requirement for HAI testing in these regions.
The key players in the global hospital acquired disease testing market are
- Diatherix laboratories
- Life technologies
- Cantel Medical Corporation Meridian Biosciences
- Qiagen GmbH
- Nordion
- Roche
- Cepheid & others
Buy Now This Report @ https://www.coherentmarketinsights.com/insight/buy-now/992
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Hospital Acquired Disease Testing Market: A Close Look to Market Value and Witness a Robust CAGR of 19.70% by 2025